8,566
Total Claims
$1.1M
Drug Cost
1,014
Beneficiaries
$1,087
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-29%
Cost per patient vs peers
$1,087 vs $1,524 avg
+11%
Brand preference vs peers
15.1% vs 13.7% avg
Brand vs Generic
85% generic
Brand: 1,295 claims · $966K
Generic: 7,271 claims · $136K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 550 | $464K |
| Rivaroxaban | 160 | $124K |
| Evolocumab | 131 | $118K |
| Sacubitril/Valsartan | 62 | $70K |
| Alirocumab | 87 | $68K |
| Dronedarone Hcl | 24 | $25K |
| Icosapent Ethyl | 26 | $18K |
| Empagliflozin | 19 | $12K |
| Metoprolol Succinate | 580 | $9,867 |
| Ranolazine | 92 | $9,060 |
| Icosapent Ethyl | 20 | $7,370 |
| Losartan Potassium | 506 | $6,304 |
| Ezetimibe | 193 | $6,099 |
| Atorvastatin Calcium | 404 | $5,206 |
| Rosuvastatin Calcium | 311 | $4,666 |
Prescribing Profile
63
Unique Drugs
$670K
Patient Profile
75
Avg Age
61%
Female
1.50
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data